Impact of the kinetics of circulating anti‐BCMA CAR‐T cells and normal lymphocytes on the outcome of MM patients
Year: 2025
Type: article
Language: en
Topic: CAR-T cell therapy research
Authors and affiliations:
raw_author_name: Sara Gutiérrez‐Herrero
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Cytometry Service (NUCLEUS) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC) University of Salamanca (Universidad de Salamanca) Salamanca Spain
raw_author_name: Lourdes Martín‐Martín
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Cytometry Service (NUCLEUS) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC) University of Salamanca (Universidad de Salamanca) Salamanca Spain
raw_author_name: María Herrero‐García
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Cytometry Service (NUCLEUS) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC) University of Salamanca (Universidad de Salamanca) Salamanca Spain
raw_author_name: Borja Puertas
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Department of Hematology University Hospital of Salamanca (HUS/IBSAL) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
raw_author_name: Eduarda da Silva Barbosa
raw_affiliation_strings: Internal Medicine Postgraduate Program, Faculty of Medicine, Department of Internal Medicine University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro (UFRJ)  Rio de Janeiro Brazil
raw_author_name: María Victoria Mateos
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Department of Hematology University Hospital of Salamanca (HUS/IBSAL) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
raw_author_name: Lucía López‐Corral
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Department of Hematology University Hospital of Salamanca (HUS/IBSAL) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
raw_author_name: Verónica González‐Calle
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Department of Hematology University Hospital of Salamanca (HUS/IBSAL) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
raw_author_name: Beatriz Rey‐Búa
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Department of Hematology University Hospital of Salamanca (HUS/IBSAL) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
raw_author_name: Ana África Martín‐López
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Department of Hematology University Hospital of Salamanca (HUS/IBSAL) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
raw_author_name: Estefanía Pérez‐López
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Department of Hematology University Hospital of Salamanca (HUS/IBSAL) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
raw_author_name: Fermín Sánchez‐Guijo
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Department of Hematology University Hospital of Salamanca (HUS/IBSAL) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
raw_author_name: Miriam López‐Parra
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Department of Hematology University Hospital of Salamanca (HUS/IBSAL) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
raw_author_name: Noemí Puig
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Department of Hematology University Hospital of Salamanca (HUS/IBSAL) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
raw_author_name: Alberto Orfao
raw_affiliation_strings: CIBERONC University of Salamanca and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain
Cytometry Service (NUCLEUS) Salamanca Spain
Department of Medicine University of Salamanca (Universidad de Salamanca) Salamanca Spain
Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain
Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC) University of Salamanca (Universidad de Salamanca) Salamanca Spain